Clinical Handbook of Psychotropic Drugs

by Bezchlibnyk-Butler, Kalyna Z.; Jeffries, J. Joel

• ISBN13: 9780889372467
• ISBN10: 0889372462
• Edition: 11th
• Format: Paperback
• Copyright: 2001-05-01
• Publisher: Hogrefe & Huber Pub

Summary

Clarke Institute of Psychiatry, Toronto, Canada. Annual quick reference for psychiatrists, pharmacists, and psychiatric nurses. Summarizes psychotropic medications in a tabular format. Landscape format. Wire-spiral binding.

Table of Contents

Antidepressants	p. 2
Selective Serotonin Reuptake Inhibitors (SSRI)	p. 3
Norepinephrine Dopamine Reuptake Inhibitor (NDRI)	p. 14
Selective Serotonin Norepinephrine Reuptake Inhibitor (SNRI)	p. 18
Serotonin-2 Antagonists/Reuptake Inhibitors (SARI)	p. 21
Noradrenergic/Specific Serotonergic Antidepressant (NaSSA)	p. 27
Non-Selective Cyclic Antidepressants	p. 30
Effects of Antidepressants on Neurotransmitters/Receptors	p. 39
Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors	p. 40
Frequency of Adverse Reactions to Cyclic Antidepressants at Therapeutic Doses	p. 41
Reversible Inhibitor of MAO-A (RIMA)	p. 43
Irreversible Monoamine Oxidase Inhibitors	p. 47
Frequency of Adverse Reactions to MAOI Antidepressants at Therapeutic Doses	p. 53
Antidepressant Doses	p. 54
Switching Antidepressants	p. 56
Antidepressant Augmentation Strategies	p. 57
Electroconvulsive Therapy (ECT)	p. 59
Antipsychotics (Neuroleptics)	p. 64
"Novel" Antipsychotics (Neuroleptics)	p. 72
"Conventional" Antipsychotics (Neuroleptics)	p. 78
Effects of Antipsychotics on Neurotransmitters/Receptors	p. 85
Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptors	p. 86
Frequency of Adverse Reactions to Antipsychotics at Therapeutic Doses	p. 87
Antipsychotic Doses	p. 89
Comparison of Depot Antipsychotics	p. 92
Extrapyramidal Side Effects of Antipsychotics	p. 94
Switching Antipsychotics	p. 97
Antipsychotic Augmentation Strategies	p. 98
Antiparkinsonian Agents	p. 100
Effects on Extrapyramidal Symptoms	p. 104
Comparison of Antiparkinsonian Agents	p. 105
Anxiolytic Agents	p. 107
Benzodiazepines	p. 107
Comparison of the Benzodiazepines	p. 115
Buspirone	p. 119
Hypnotics/Sedatives	p. 122
Comparison of Hypnotics/Sedatives	p. 127
Mood Stabilizers	p. 131
Lithium	p. 131
Anticonvulsants	p. 138
L-Tryptophan	p. 153
Psychostimulants	p. 156
Comparison of Psychostimulants	p. 161
Cognition Enhancers	p. 163
Comparison of Acetylcholinesterase Inhibitors	p. 167
Sex-Drive Depressants	p. 169
Comparison of Sex-Drive Depressants	p. 170
Drugs of Abuse	p. 172
Alcohol	p. 175
Hallucinogens	p. 178
Stimulants	p. 183
Opiates/Narcotics	p. 186
Inhalants/Aerosols	p. 190
Gamma Hydroxy Butyrate (GHB)	p. 191
Flunitrazepam	p. 183
Treatment of Substance Use Disorders	p. 194
Disulfiram	p. 194
Naltrexone	p. 197
Methadone	p. 199
New Unapproved Treatments of Psychiatric Disorders	p. 202
Adrenergic Agents	p. 204
Calcium Channel Blockers	p. 206
Cholinergic Agents	p. 207
Dopaminergic Agents	p. 207
GABA-Agents/Anticonvulsants	p. 208
Peptides	p. 209
Serotonergic Agents	p. 209
Serotonin Antagonists	p. 210
Steroid Biosynthesis Inhibitors	p. 211
Miscellaneous	p. 211
Herbal and Natural Products	p. 214
Glossary	p. 218
Suggested Readings	p. 221
Index of Drugs	p. 225
Patient Information Sheets	p. 231
Table of Contents provided by Syndetics. All Rights Reserved.